A potent inhibitor of phosphatidic acid generation
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

(±)-Lisofylline

Item No. 10010785

Technical Information
Formal Name
3,7-dihydro-1-(5-hydroxyhexyl)-3,7-dimethyl-1H-purine-2,6-dione
CAS Number
6493-06-7
Synonyms
  • BL 194
  • CT-1501R
  • LSF
Molecular Formula
C13H20N4O3
Formula Weight
Purity
≥98%
A crystalline solid
DMF: 10 mg/mlDMSO: 10 mg/mlEthanol: 2 mg/mlPBS (pH 7.2): 1 mg/ml
λmax
274 nm
SMILES
CC(O)CCCCn1c(=O)c2n(C)cnc2n(C)c1=O
InChi Code
InChI=1S/C13H20N4O3/c1-9(18)6-4-5-7-17-12(19)10-11(14-8-15(10)2)16(3)13(17)20/h8-9,18H,4-7H2,1-3H3
InChi Key
NSMXQKNUPPXBRG-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Explore Obesity & Metabolic Disease Resources

    Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.

    OBESITY RESEARCH SOLUTIONS
    Product Description

    (±)-Lisofylline (LSF) is a potent anti-inflammatory agent in which only the (−) optical isomer is biologically active.1,2 LSF inhibits the generation of phosphatidic acid (IC50 = 0.6 µM) from cytokine-activated lysophosphatidic acyl transferase (LPAAT), which has been shown to protect mice from endotoxic shock.3 LSF suppresses the production of the proinflammatory cytokine IFN-γ, inhibits IL-12-mediated STAT-4 activation, and enhances glucose-stimulated β-cell insulin secretion, reducing the onset of diabetes in a non-obese diabetic mouse model.1,4

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Yang, Z., Chen, M., Ellett, J.D., et alInflammatory blockade improves human pancreatic islet function and viability. Am. J. Transplant. 5(3), 475-483 (2005).

    2. Wyska, E., Pekala, E., and Szymura-Oleksiak, J. Interconversion and tissue distribution of pentoxifylline and lisofylline in mice. Chirality 18(8), 644-651 (2006).

    3. Rice, G.C., Brown, P.A., Nelson, R.J., et alProtection from endotoxic shock in mice by pharmacologic inhibition of phosphatidic acid. Proc. Natl. Acad. Sci. USA 91(9), 3857-3861 (1994).

    4. Yang, Z.D., Chen, M., Wu, R., et alThe anti-inflammatory compound lisofylline prevents type I diabetes in non-obese diabetic mice. Diabetologia 45(9), 1307-1314 (2002).